Encyclopedia
Elisrasib
Investigational drug
Elisrasib is an investigational new drug that is being developed by D3 Bio for the treatment of solid tumors. It is a G12C mutant selective KRAS inhibitor.
Sources and credits
This article is adapted from the Wikipedia article “Elisrasib”, written by its contributors and licensed under CC BY-SA 4.0. Fathomly has changed the layout, removed citation markers, navigation and maintenance notices, and adjusted punctuation. This adapted version is shared under the same license. For references, see the original article.
Images, from Wikimedia Commons:
- Elisrasib.svg by Boghog, CC0
Fathomly is not affiliated with or endorsed by the Wikimedia Foundation. Spotted a problem? Tell us.